BL Pharmtech Corp.
Research BL Pharmtech Corp. (065170.KQ) on Bullrun: market cap KRW 57.91B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker065170.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorConsumer Defensive
- IndustryFood Distribution
- CurrencyKRW
- Market capKRW 57.91B
- Financial periodQ2 2026
- RevenueKRW 713.41M
- Net income-KRW 802.75M
- Free cash flow-KRW 589.63M
- Gross margin33.7%
Valuation Snapshot
latest market cap is KRW 57.91B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 57.91B | n/a | n/a | n/a |
Dividend history
About BL Pharmtech Corp.
BL Pharmtech Corp. manufactures, retails, imports, and exports health functional foods in South Korea. It is also involved in biotechnology business, as well as manufacture of cosmetics. The company was formerly known as Next BT Co., Ltd. BL Pharmtech Corp. was founded in 1995 and is headquartered in Yongin-si, South Korea.
Related stock research
Other Consumer Defensive stocks
Frequently asked questions
What is BL Pharmtech Corp.'s market cap?
BL Pharmtech Corp.'s market capitalization is KRW 57.91B.
What does BL Pharmtech Corp. do?
BL Pharmtech Corp. manufactures, retails, imports, and exports health functional foods in South Korea. It is also involved in biotechnology business, as well as manufacture of cosmetics. The company was formerly known as Next BT Co., Ltd. BL Pharmtech Corp. was founded in 1995 and is headquartered in Yongin-si, South Korea.